TrialMolecular cancer2024

Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide.

Maud Toulmonde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.